Barclays Maintains Underweight on Virtus Inv, Lowers Price Target to $135

Benzinga Newsdesk www.benzinga.com Negative 88.6%

Neg 88.6% Neu 0% Pos 0%

Barclays analyst Benjamin Budish maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $141 to $135.